1. Home
  2. NAGE vs FLGT Comparison

NAGE vs FLGT Comparison

Compare NAGE & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAGE
  • FLGT
  • Stock Information
  • Founded
  • NAGE 1999
  • FLGT 2011
  • Country
  • NAGE United States
  • FLGT United States
  • Employees
  • NAGE N/A
  • FLGT N/A
  • Industry
  • NAGE Medicinal Chemicals and Botanical Products
  • FLGT Medical Specialities
  • Sector
  • NAGE Health Care
  • FLGT Health Care
  • Exchange
  • NAGE Nasdaq
  • FLGT Nasdaq
  • Market Cap
  • NAGE 594.0M
  • FLGT 508.7M
  • IPO Year
  • NAGE N/A
  • FLGT 2016
  • Fundamental
  • Price
  • NAGE $6.76
  • FLGT $17.86
  • Analyst Decision
  • NAGE Strong Buy
  • FLGT Hold
  • Analyst Count
  • NAGE 1
  • FLGT 1
  • Target Price
  • NAGE $11.00
  • FLGT $16.00
  • AVG Volume (30 Days)
  • NAGE 665.7K
  • FLGT 620.1K
  • Earning Date
  • NAGE 05-07-2025
  • FLGT 05-02-2025
  • Dividend Yield
  • NAGE N/A
  • FLGT N/A
  • EPS Growth
  • NAGE N/A
  • FLGT N/A
  • EPS
  • NAGE 0.11
  • FLGT N/A
  • Revenue
  • NAGE $99,597,000.00
  • FLGT $283,470,000.00
  • Revenue This Year
  • NAGE $21.53
  • FLGT $11.70
  • Revenue Next Year
  • NAGE $20.87
  • FLGT $9.90
  • P/E Ratio
  • NAGE $61.45
  • FLGT N/A
  • Revenue Growth
  • NAGE 19.18
  • FLGT N/A
  • 52 Week Low
  • NAGE $2.31
  • FLGT $14.57
  • 52 Week High
  • NAGE $9.18
  • FLGT $25.11
  • Technical
  • Relative Strength Index (RSI)
  • NAGE N/A
  • FLGT 52.97
  • Support Level
  • NAGE N/A
  • FLGT $16.71
  • Resistance Level
  • NAGE N/A
  • FLGT $19.41
  • Average True Range (ATR)
  • NAGE 0.00
  • FLGT 0.87
  • MACD
  • NAGE 0.00
  • FLGT 0.11
  • Stochastic Oscillator
  • NAGE 0.00
  • FLGT 51.03

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Share on Social Networks: